Stay updated on Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Sign up to get notified when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.

Latest updates to the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision tag 'Revision: v3.6.3' was added and the previous 'Revision: v3.6.2' was removed in the page history. This reflects a minor update to the page's revision metadata rather than any changes to the study content.SummaryDifference0.1%

- Check19 days agoChange DetectedA new revision entry v3.6.2 was added to the record history and an older revision v3.6.0 was removed, updating the page's version history to reflect the latest administrative update.SummaryDifference0.1%

- Check34 days agoChange DetectedRecruitment status was updated to indicate the study is no longer enrolling participants. The record revision was updated to version 3.6.0, replacing the prior 3.5.5 in the history.SummaryDifference0.3%

- Check41 days agoChange DetectedA new revision label 'Revision: v3.5.5' has been added to the study history, replacing the previous 'Revision: v3.5.4' and indicating an update to the record's revision level.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision label 'Revision: v3.5.4' was added to the page history. This replaces the previous 'Revision: v3.5.3' in the history and signals an update to the record's revision metadata.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page’s software/version footer was updated from Revision v3.5.2 to Revision v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.